Also, a discrepancy has been reported between diffuse cytoplasmatic CXCR4 in 81% compared to membrane-localized CXCR4 in only 25% of breast tumors using immunohistochemistry staining [54,55]. This evidence concerns the gene CXCR4 and breast neoplasm.